 |
1,5-(Butylimino)-1,5 dideoxy,D-glucitol |
|---|---|
| Trade Name | |
| Orphan Indication | Fabry disease |
| USA Market Approval | USA |
| USA Designation Date | 1998-05-12 00:00:00 |
| Sponsor | Oxford GlycoSciences;10, The Quadrant, Abington Science Park;United Kingdom |
Related Access Program